Company / Interest Expense
PLUS THERAPEUTICS, INC. Interest Expense History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.0M
FY2018
5-year range
$2.0M / $3.4M
FY2014-FY2018
Trend
-20.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has declined for 3 consecutive years, from $3M in FY2015 to $2M in FY2018.
Based on SEC 10-K filings.
$2M in FY2018 with a 5-year CAGR of -5.9%.
Improved from $3M to $2M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- PLUS THERAPEUTICS, INC.'s interest expense has declined for 3 consecutive years.
- 5-year CAGR of -5.9%, indicating a declining trend.
- In FY2018, interest expense decreased 20.9% year-over-year.
- Peak interest expense was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | $2.0M | -20.9% |
| FY2017 | $2.6M | -23.3% |
| FY2016 | $3.4M | -0.5% |
| FY2015 | $3.4M | +0.3% |
| FY2014 | $3.4M | +21.6% |
| FY2013 | $2.8M | +35.7% |
| FY2012 | $2.1M | +43.8% |
| FY2011 | $1.4M | - |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026